Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01D OTHER BETA-LACTAM ANTIBACTERIALS
J01DE Fourth-generation cephalosporins
J01DE51 Cefepime and beta-lactamase inhibitor
D12818 Cefepime hydrochloride and enmetazobactam
USP drug classification [BR:br08302]
Antibacterials
Beta-lactam, Cephalosporins
Cefepime/ Enmetazobactam
D12818 Cefepime hydrochloride and enmetazobactam
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Fourth-generation cephalosporin
D12818 Cefepime hydrochloride and enmetazobactam
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D12818
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D12818
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D12818